Nest Impex Private Limited

This company manufactures, trades, and exports pharmaceutical products, including herbal, natural, and organic compounds and formulations.

2011 | Ahmedabad, Gujarat (India) | Inactive
Last Updated: April 24, 2024

Nest Impex Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 3 Months
  • Last Filing with ROC 31 Mar 2016
  • Revenue Growth %
  • Profit Growth 18.20%
  • Ebitda 18.20%
  • Net Worth -0.94%
  • Total Assets -0.28%

About Nest Impex

Nest Impex Private Limited (NIPL) is Strike Off company established on 21 Oct 2011 with its office registered at Ahmedabad, Gujarat, India and has been running since 13 Year, 3 Months with a paid up capital of 0.10 M. According to MCA records, 2 Directors are linked to this company as of 24 Apr 2024.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U51397GJ2011PTC067574

  • Company No.

    067574

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Oct 2011

  • Date of AGM

    30 Sep 2016

  • Date of Balance Sheet

    31 Mar 2016

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

Who are the key members and board of directors at Nest Impex?

Board Members (2)

Name Designation Appointment Date Status
Riya Patel Country flag representing In Director 29-Jan-2015 Current
Nayanaben Shah Country flag representing In Director 26-Oct-2015 Current

Financial Performance of Nest Impex.

Nest Impex Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 18.2% increase in profit. The company's net worth dipped by a decrease of 0.94%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-0.28%
Profit or Loss
18.20%
Net Worth
-0.94%
EBITDA
18.20%

What is the Ownership and Shareholding Structure of Nest Impex?

In 2016, Nest Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Nest Impex?

Unlock and access historical data on people associated with Nest Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nest Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nest Impex's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Nest Impex

Recent activity within the organization

  • Annual General Meeting

    Nest Impex Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.

    30 Sep 2016

  • Balance Sheet

    Nest Impex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Ahmedabad.

    31 Mar 2016

  • Director Appointment

    Nayanaben Arvindbhai Shah was appointed as a Director was appointed as a Director on 26 Oct 2015 & has been associated with this company since 9 years 3 months .

    26 Oct 2015

  • Director Appointment

    Riya Pravinkumar Patel was appointed as a Director was appointed as a Director on 29 Jan 2015 & has been associated with this company since 10 years 7 days .

    29 Jan 2015

  • Company Incorporation

    Nest Impex Private Limited was registered on 21 Oct 2011 with Roc Ahmedabad & aged 13 years 3 months as per MCA records.

    21 Oct 2011

Frequently asked questions

  • Nest Impex Private Limited was incorporated on 21 Oct 2011.

  • The authorized share capital of Nest Impex Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Nest Impex Private Limited.

    • Riya Pravinkumar Patel
    • Nayanaben Arvindbhai Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of Nest Impex Private Limited is C/27 Samatra Complex Bh. Sahara Township, Gam - Shela Bopal, Ahmedabad, Gujarat, India, 380058.

  • The corporate identification number (CIN) of Nest Impex Private Limited is U51397GJ2011PTC067574 and the company number is 067574 as per Ministry of Corporate Affairs (MCA).

  • The financial reports for the fiscal year 2016 indicates that The net worth of Nest Impex Private Limited has experienced an downturn of -0.94%.

  • The most recent Balance Sheet for Nest Impex Private Limited was filed with the ROC on 31 Mar 2016.

Similar Companies Based on Drug Formulation & Development